Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Management of Adult Minimal Change Disease.

Korbet SM, Whittier WL.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):911-913. doi: 10.2215/CJN.01920219. Epub 2019 Apr 5. No abstract available.

PMID:
30952629
2.

Changing Trends in the Performance of Percutaneous Renal Biopsy from Nephrologist to Interventional Radiologist: A Single-Center Experience.

Korbet SM, Whittier WL, Rodby RA.

Am J Nephrol. 2018;48(5):326-329. doi: 10.1159/000493925. Epub 2018 Oct 24.

3.

Without Warning: Scleroderma Renal Crisis.

Lichtenstein SJ, Herring MJ, Baxi PV, Abrams RI, Korbet SM.

Am J Med. 2019 Feb;132(2):175-178. doi: 10.1016/j.amjmed.2018.09.024. Epub 2018 Oct 2. No abstract available.

PMID:
30290189
4.

Comparison of native and transplant kidney biopsies: diagnostic yield and complications.

Whittier WL, Gashti C, Saltzberg S, Korbet S.

Clin Kidney J. 2018 Oct;11(5):616-622. doi: 10.1093/ckj/sfy051. Epub 2018 Jul 6.

5.

Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury.

Korbet SM, Gashti CN, Evans JK, Whittier WL.

Clin Kidney J. 2018 Oct;11(5):610-615. doi: 10.1093/ckj/sfy048. Epub 2018 Jul 2.

6.

Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.

Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez-Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Solomons N, Houssiau FA, Romero-Diaz J, Mejia-Vilet J, Rovin BH.

Arthritis Rheumatol. 2019 Mar;71(3):411-419. doi: 10.1002/art.40724. Epub 2019 Feb 1.

PMID:
30225865
7.

The Impact of Baseline Serum Creatinine on Complete Remission Rate and Long-Term Outcome in Patients with Severe Lupus Nephritis.

Collaborative Study Group, Korbet SM, Whittier WL, Lewis EJ.

Nephron Extra. 2016 Aug 18;6(2):12-21. eCollection 2016 May-Aug.

8.

Clinical factors influencing the decision to transfuse after percutaneous native kidney biopsy.

Whittier WL, Sayeed K, Korbet SM.

Clin Kidney J. 2016 Feb;9(1):102-7. doi: 10.1093/ckj/sfv128. Epub 2015 Dec 15.

9.

Elevated serum creatinine in a patient with normal renal function: the value of Cystatin C.

Sahota S, Rodby RA, Korbet SM.

Nephrology (Carlton). 2015 May;20(5):383-4. doi: 10.1111/nep.12399. No abstract available.

PMID:
25872661
10.

Adequacy and complication rates with 14- vs. 16-gauge automated needles in percutaneous renal biopsy of native kidneys.

Chunduri S, Whittier WL, Korbet SM.

Semin Dial. 2015 Mar-Apr;28(2):E11-4. doi: 10.1111/sdi.12332. Epub 2014 Nov 30.

PMID:
25441680
11.

Who should perform the percutaneous renal biopsy: a nephrologist or radiologist?

Whittier WL, Korbet SM.

Semin Dial. 2014 May-Jun;27(3):243-5. doi: 10.1111/sdi.12215. Epub 2014 Mar 13. Review. No abstract available.

PMID:
24621389
12.

Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies.

Korbet SM, Volpini KC, Whittier WL.

Am J Nephrol. 2014;39(2):153-62. doi: 10.1159/000358334. Epub 2014 Feb 11.

PMID:
24526094
13.

The variable course of women with X-linked Alport Syndrome.

Raju P, Cimbaluk D, Korbet SM.

Clin Kidney J. 2013 Dec;6(6):630-634. Epub 2013 Aug 26.

14.

Severe lupus nephritis: the predictive value of a ≥ 50% reduction in proteinuria at 6 months.

Korbet SM, Lewis EJ; Collaborative Study Group.

Nephrol Dial Transplant. 2013 Sep;28(9):2313-8. doi: 10.1093/ndt/gft201. Epub 2013 Jun 19.

PMID:
23787551
15.

The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.

Sinsakul M, Sika M, Koury M, Shapiro W, Greene T, Dwyer J, Smith M, Korbet S, Lewis J; Collaborative Study Group.

Nephron Clin Pract. 2012;121(1-2):c25-9. doi: 10.1159/000341922. Epub 2012 Oct 16.

PMID:
23075669
16.

Treatment of primary FSGS in adults.

Korbet SM.

J Am Soc Nephrol. 2012 Nov;23(11):1769-76. doi: 10.1681/ASN.2012040389. Epub 2012 Sep 20. Review.

17.

Nephrology and the percutaneous renal biopsy: a procedure in jeopardy of being lost along the way.

Korbet SM.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1545-7. doi: 10.2215/CJN.08290812. Epub 2012 Sep 13. No abstract available.

18.

Complete remission in severe lupus nephritis: assessing the rate of loss in proteinuria.

Korbet SM, Lewis EJ; Collaborative Study Group.

Nephrol Dial Transplant. 2012 Jul;27(7):2813-9. doi: 10.1093/ndt/gfr741. Epub 2011 Dec 23.

PMID:
22199359
19.

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA.

J Am Soc Nephrol. 2011 Nov;22(11):2129-37. doi: 10.1681/ASN.2011040388. Epub 2011 Oct 13.

20.

The Oxford classification of IgA nephropathy: a retrospective analysis.

Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ.

Am J Nephrol. 2011;34(5):435-44. doi: 10.1159/000332223. Epub 2011 Sep 28.

PMID:
21968096
21.

Pruritic rash and eosinophilia in a patient receiving peritoneal dialysis.

Patel UO, Fox SR, Moy JN, Korbet SM.

Semin Dial. 2011 May-Jun;24(3):338-40. doi: 10.1111/j.1525-139X.2011.00937.x.

PMID:
21682774
22.

The prognosis of severe lupus nephritis based on the Modification of Diet in Renal Disease (MDRD) study estimated glomerular filtration rate.

Patel SB, Korbet SM, Lewis EJ.

Lupus. 2011 Mar;20(3):256-64. doi: 10.1177/0961203310385267. Epub 2010 Dec 7.

PMID:
21138981
23.

Pathogenetic features of severe segmental lupus nephritis.

Behara VY, Whittier WL, Korbet SM, Schwartz MM, Martens M, Lewis EJ.

Nephrol Dial Transplant. 2010 Jan;25(1):153-9. doi: 10.1093/ndt/gfp424. Epub 2009 Aug 23.

PMID:
19703837
24.

The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys.

Waldo B, Korbet SM, Freimanis MG, Lewis EJ.

Nephrol Dial Transplant. 2009 Aug;24(8):2433-9. doi: 10.1093/ndt/gfp073. Epub 2009 Feb 25.

PMID:
19246472
25.

Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis.

Schwartz MM, Korbet SM, Katz RS, Lewis EJ.

Lupus. 2009 Feb;18(2):149-58. doi: 10.1177/0961203308095947.

PMID:
19151117
26.

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA.

Nat Genet. 2008 Oct;40(10):1175-84. doi: 10.1038/ng.226. Epub 2008 Sep 14.

27.

Intravascular hemolysis and acute renal failure after mitral and aortic valve repair.

Concepcion B, Korbet SM, Schwartz MM.

Am J Kidney Dis. 2008 Nov;52(5):1010-5. doi: 10.1053/j.ajkd.2008.03.021. Epub 2008 May 29. No abstract available.

PMID:
18511167
28.

A case of polyneuropathy and proteinuria.

Korbet SM, Bonsib S.

Clin J Am Soc Nephrol. 2008 Mar;3(2):624-36. doi: 10.2215/CJN.03440807. Epub 2008 Feb 13. No abstract available.

29.

Long-term Outcome of Adult Onset Idiopathic Minimal Change Disease.

Colattur SN, Korbet SM.

Saudi J Kidney Dis Transpl. 2000 Jul-Sep;11(3):334-44.

30.

APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.

Rovin BH, Roncone D, McKinley A, Nadasdy T, Korbet SM, Schwartz MM.

N Engl J Med. 2007 Dec 13;357(24):2522-4. No abstract available.

PMID:
18077821
31.

The prognosis and pathogenesis of severe lupus glomerulonephritis.

Schwartz MM, Korbet SM, Lewis EJ; Collaborative Study Group.

Nephrol Dial Transplant. 2008 Apr;23(4):1298-306. Epub 2007 Nov 28.

PMID:
18045825
32.

Value of a complete or partial remission in severe lupus nephritis.

Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ; Collaborative Study Group.

Clin J Am Soc Nephrol. 2008 Jan;3(1):46-53. Epub 2007 Nov 14.

33.

NPHS2 variation in sporadic focal segmental glomerulosclerosis.

McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki MH, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA.

J Am Soc Nephrol. 2007 Nov;18(11):2987-95. Epub 2007 Oct 17.

34.

Immuotactoid glomerulopathy (fibrillary glomerulonephritis).

Korbet SM, Schwartz MM, Lewis EJ.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1351-6. Epub 2006 Sep 13. No abstract available.

35.

Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.

Reddy NC, Korbet SM, Wozniak JA, Floramo SL, Lewis EJ.

Nephrol Dial Transplant. 2007 May;22(5):1399-406. Epub 2007 Jan 27.

PMID:
17259652
36.

Severe lupus nephritis: racial differences in presentation and outcome.

Korbet SM, Schwartz MM, Evans J, Lewis EJ; Collaborative Study Group.

J Am Soc Nephrol. 2007 Jan;18(1):244-54. Epub 2006 Dec 13.

37.

Multiple myeloma.

Korbet SM, Schwartz MM.

J Am Soc Nephrol. 2006 Sep;17(9):2533-45. Epub 2006 Aug 2. Review. No abstract available.

38.

Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs.

Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ.

Am J Kidney Dis. 2005 Apr;45(4):758-61. Erratum in: Am J Kidney Dis. 2005 Jul;46(1):171.

PMID:
15806479
39.

Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population.

Orloff MS, Iyengar SK, Winkler CA, Goddard KA, Dart RA, Ahuja TS, Mokrzycki M, Briggs WA, Korbet SM, Kimmel PL, Simon EE, Trachtman H, Vlahov D, Michel DM, Berns JS, Smith MC, Schelling JR, Sedor JR, Kopp JB.

Physiol Genomics. 2005 Apr 14;21(2):212-21. Epub 2005 Feb 1.

40.

Glomerular podocytopathy in patients with systemic lupus erythematosus.

Kraft SW, Schwartz MM, Korbet SM, Lewis EJ.

J Am Soc Nephrol. 2005 Jan;16(1):175-9. Epub 2004 Nov 17.

41.

Renal biopsy: update.

Whittier WL, Korbet SM.

Curr Opin Nephrol Hypertens. 2004 Nov;13(6):661-5. Review.

PMID:
15483458
42.
43.

Timing of complications in percutaneous renal biopsy.

Whittier WL, Korbet SM.

J Am Soc Nephrol. 2004 Jan;15(1):142-7.

44.
45.

Treatment of primary focal segmental glomerulosclerosis.

Korbet SM.

Kidney Int. 2002 Dec;62(6):2301-10. No abstract available.

46.

Percutaneous renal biopsy.

Korbet SM.

Semin Nephrol. 2002 May;22(3):254-67. Review.

PMID:
12012311
47.

Immunotactoid glomerulopathy.

Schwartz MM, Korbet SM, Lewis EJ.

J Am Soc Nephrol. 2002 May;13(5):1390-7. Review. No abstract available.

48.

The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis.

Kim GC, Vonesh EF, Korbet SM.

Perit Dial Int. 2002 Jan-Feb;22(1):53-9.

PMID:
11929145
49.

Severe lupus nephritis: importance of re-evaluating the histologic classification and the approach to patient care.

Lewis EJ, Schwartz MM, Korbet SM.

J Nephrol. 2001 Jul-Aug;14(4):223-7. Review.

PMID:
11506244
50.

Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis.

Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J; Lupus Nephritis Collaborative Study Group.

Kidney Int. 2001 Jun;59(6):2156-63.

Supplemental Content

Loading ...
Support Center